Page last updated: 2024-08-21

thiazolidines and Rectal Neoplasms

thiazolidines has been researched along with Rectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Carnero, A; Fernández-Fernández, MC; García-Heredia, JM; Martinez-Pérez, J; Muñoz-Galván, S; Ortiz, MJ; Peinado-Serrano, J; Rivero, M	1

Other Studies

1 other study(ies) available for thiazolidines and Rectal Neoplasms

Article	Year
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells, 2020, 04-25, Volume: 9, Issue:5 Topics: Adult; Aged; Apoptosis; Biomarkers, Pharmacological; Biomarkers, Tumor; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Plasminogen Activator Inhibitor 1; Prognosis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rectal Neoplasms; Thiazolidines	2020

Article

Year

PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.

Cells, 2020, 04-25, Volume: 9, Issue:5

Topics: Adult; Aged; Apoptosis; Biomarkers, Pharmacological; Biomarkers, Tumor; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Plasminogen Activator Inhibitor 1; Prognosis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rectal Neoplasms; Thiazolidines

2020